samedan logo

 
 
spacer
home > ebr > spring 2003 > partners with vision - a discussion on the future of pharma
PUBLICATIONS
European Biopharmaceutical Review

Partners With Vision - A Discussion on the Future of Pharma

No single person can accurately predict the future of the pharmaceutical industry. Unprecedented competition, a weak economy, pricing pressures, public scrutiny and ever-increasing regulation characterise the current environment. In the face of these business challenges, some organisations are achieving exciting innovations while others' efforts have been stifled. Many companies are surmounting these obstacles and forging new partnerships, providing significant scientific insights to the medical community and producing lifesaving treatments to patients. However, many more companies are struggling to meet the industry's unmet challenges. While no road map exists to guide pharmaceutical companies through today's market pressures or to help them anticipate tomorrow's challenges, a vision of how the pharmaceutical industry will develop could provide benefits to the sector.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By William Powlett Smith, Audit Partner and Leader of UK Health Sciences at Ernst & Young LLP

William Powlett Smith is Audit Partner and Leader of UK Health Sciences at Ernst & Young LLP. William is well known for his extensive work with biotechnology and pharmaceutical businesses and his strong international connections, particularly with Ernst & Young's offices on the east and west coasts of the USA and in Germany.

He is now the Partner responsible for the UK firm's Health Sciences practice. Until October 1999 William was a member of the BIA's Board of Directors, and of the BIA Sub-Committee responsible for drafting the BIA's Code of Best Practice. He was a contributor to, and Co-ordinating Partner for, the production of Ernst & Young's 1998, 1999 and 2000 European Life Sciences Reports.

spacer
William Powlett Smith
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

Assessing the Integrity of Pharmaceutical Packaging Using the Sepha Blisterscan and Conventional Blue Dye Leak Testing Methods

Sepha Limited

A new whitepaper by a leading packaging expert from the University of Ulster, Dr Dorian Dixon, into the integrity of pharmaceutical packaging has established that existing methods for testing the seal integrity of blister packs are not as accurate as newer, technology based test equipment.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement